Trial intelligence / Profile preview

Juvelook for Photoaged Skin

NCT05913102Unknown

Start
Sep 2022
Primary completion
Dec 2023
Modality
Polymer-based Nanoparticles, Device-based Delivery, Small Molecules
Countries
1
01

Overview

Randomised trial of polylactic acid in photoaging and Pigmentation disorder. Primary endpoint: Lightness Value at 12 weeks. Status: unknown.

02

Drugs

polylactic acid
03

Conditions

photoagingPigmentation disorder

Beyond the preview

Go deeper on NCT05913102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05913102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call